I'm a Pathologist. Ozempic & Mounjaro Aren't Actually Weight Loss Drugs.

Ozempic and Mounjaro aren't actually weight loss drugs. I'm a pathologist, and I'm going to show you what these GLP-1 medications actually do inside your body, and the one thing that decides whether they change your life or quietly set you up to end up worse than where you started. In 2005, the FDA approved a diabetes drug. Then something nobody planned for happened. Hearts got stronger. Kidneys healed. Sleep apnea reversed. Women with PMOS (formerly called PCOS) started ovulating again. One class of drugs, doing things that on the surface have nothing to do with each other. For 20 years, that mystery didn't have a clean answer. It does now. I'm Dr. Amin Hedayat, triple board-certified physician and medical school assistant clinical professor. In this video I break down what Ozempic, Mounjaro, Wegovy, Foundayo and Zepbound actually do at the cellular level, why the miracle crowd and the poison crowd are both wrong, and the bridge framework that decides whether these drugs work for you or backfire. What you'll learn: ✅ Why GLP-1 was never really a blood sugar drug ✅ The clue from the SELECT trial that broke the case open ✅ 3 silent habits killing your body's natural GLP-1 signal ✅ The honest truth about muscle loss, cancer risk, and side effects ✅ 5 foundations that decide whether your results last ✅ What the FLOW kidney trial and the 2024 sleep apnea data show ━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 🎯 JOIN THE GET UNINFLAMED INNER CIRCLE WAITLIST Doors open July 1st. Waitlist members get first access and founding-member pricing. This is where I teach the foundations in practical, day-to-day actions: how to build meals that wake up your own GLP-1, how to protect your muscle, and how to walk into your doctor's office prepared. 👉 Join the waitlist: https://www.getuninflamed.com 📥 FREE DOWNLOAD: The GLP-1 Companion The exact framework I think every patient should walk into a GLP-1 conversation with. What to ask, what to track, what to watch for. 👉 Download free: https://www.draminhedayat.com/GLP1_co... ━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ⏱️ CHAPTERS 00:00 The Mystery (Cold Open) 02:16 Where the Drug Came From 04:13 The Clue Everyone Missed 04:58 The Real Answer: A Master Signal 06:45 Why the Signal Goes Quiet 07:10 The Bridge 09:54 Two Myths 14:03 The Five Foundations 17:25 The Bigger Picture (One Fire, Many Rooms) 18:40 What the Evidence Actually Shows 20:46 Inner Circle and Close ━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 📚 REFERENCES Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. DOI: 10.1056/NEJMoa2307563 Perkovic V, Tuttle KR, Rossing P, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med. 2024;391(2):109-121. DOI: 10.1056/NEJMoa2403347 Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391(13):1193-1205. DOI: 10.1056/NEJMoa2404881 Zhou L, Qu H, Yang L, Shou L. Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review. BMC Endocr Disord. 2023;23(1):245. DOI: 10.1186/s12902-023-01500-5 Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. DOI: 10.1056/NEJMoa2032183 Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. DOI: 10.1056/NEJMoa2206038 Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2023;389(12):1069-1084. DOI: 10.1056/NEJMoa2306963 Sanyal AJ, Newsome PN, Kliers I, et al. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. N Engl J Med. 2025;392(21):2089-2099. DOI: 10.1056/NEJMoa2413258 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 📺 SUBSCRIBE for weekly evidence-based metabolic health videos: @draminhedayat 🔗 CONNECT Instagram: @draminhedayat Website: https://www.getuninflamed.com website: http://draminhedayat.com ⚕️ MEDICAL DISCLAIMER This video is general medical education, not personal medical advice. Decisions about GLP-1 medications, dosing, and treatment belong with your own physician. No financial disclosures. Dr. Hedayat is NOT directly or indirectly affiliated with a pharmaceutical company. #Ozempic #Mounjaro #Wegovy #Zepbound #Semaglutide #Tirzepatide #GLP1 #WeightLoss #MetabolicHealth #InsulinResistance #SleepApnea #Type2Diabetes #DoctorExplains #GetUninflamed #Uninflamed